Spyre Therapeutics, Inc.

ROYAL BANK OF CANADA SYRE

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

1,317

Value ($000)

Weight

0.0%

2019 Q4 - 2023 Q2 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	1	0.0%	1,317	6/30/2023
2022 Q3	11/14/2022	1	0.0%	1,401	9/30/2022
2022 Q2	8/15/2022	0	0.0%	674	6/30/2022
2022 Q1	5/16/2022	6	0.0%	2,483	3/31/2022
2021 Q4	2/14/2022	39	0.0%	8,160	12/31/2021
2021 Q3	11/15/2021	44	0.0%	5,468	9/30/2021
2021 Q2	8/16/2021	20	0.0%	2,966	6/30/2021
2021 Q1	7/20/2021	32	0.0%	3,949	3/31/2021
2020 Q4	2/16/2021	15	0.0%	1,868	12/31/2020
2020 Q3	11/16/2020	1	0.0%	200	9/30/2020
2020 Q2	8/14/2020	2	0.0%	238	6/30/2020
2020 Q1	6/16/2020	2	0.0%	329	3/31/2020
2019 Q4	2/14/2020	18	0.0%	2,277	12/31/2019